Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

NCT00263874 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
324
Enrollment
INDUSTRY
Sponsor class

Stopped The decision to terminate was completely related to efficacy and there were no safety concerns.

Conditions

Interventions

Sponsor

Pfizer